Figure S4 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells

Soyoung Lee; Kyunghwan Kim; Hye‐Jin Jeong; Subin Choi; Himchan Cheng; Dayoung Kim; Soomin Heo; Jinhee Mun; Minjong Kim; Eunjin Lee; Yoon Ji Choi; Seon‐gyeong Lee; Eun A Lee; Yewon Jang; Kayeong Lim; Heon Seok Kim; Euihwan Jeong; Seung‐Jae Myung; Deok‐Beom Jung; Chang Sik Yu; In Ho Song; M. Ryan Corces; Joo H. Kang; Kyungjae Myung; Taejoon Kwon; Tae‐Eun Park; Jinmyoung Joo; Seung Woo Cho

doi:10.1158/0008-5472.29760179

Key Points

MAIN FINDING: Evaluating the combination of CRISPR and PARP inhibitors shows increased cytotoxicity in cancer cells.
KEY EVIDENCE: The study assesses the specificity and safety of CRISPR-induced effects on non-target loci.
APPROACH: The research uses multiplexed CRISPR technology across various cell lines to analyze results.
SIGNIFICANCE: These findings suggest a more effective method for targeting cancer cells while minimizing side effects.

Implication

Analysis shows CRISPR enhances cytotoxicity in cancer cells, indicating its precise targeting potential.

Abstract

Figure S4 evaluates the specificity and safety of multiplexed CRISPR-induced cytotoxicity by examining its effects on non-target loci and various cell lines.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d029e https://doi.org/10.1158/0008-5472.29760179

View Full Paper

Ask AI

Bookmark

Share

Figure S4 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells

Key Points

Implication

Abstract

Discussion

Cite This Study

Figure S4 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading